# CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
> **ANDA211476** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2021-11-02
## Drug
- **FDA Application Number:** ANDA211476
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
- **Generic name:** Chlordiazepoxide Hydrochloride
- **Active ingredients:** CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2021-11-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211476)
---
*MORVS · CC0 1.0*